Why Tilray Stock Climbed More Than 14% Tuesday

Motley Fool2021-10-20
The Canadian cannabis retailer made a big leadership move and saw its stock rise the most in one day since mid-July.

Key Points

  • Tilray added a new president.
  • The meme-stock favorite has been volatile.

What happened

Tilray(NASDAQ:TLRY)stock climbed more than 14% on Tuesday. The Canadian cannabis company opened at $10.17, then rose to as high as $11.63 during the day. The stock was as high as $63.91 in February, but has been on a steady decline since.

So what

Tilray shook up its management team on Tuesday, appointing former Bacardi executive Blair MacNeil as the company's president. According to Tilray, MacNeil will oversee sales, marketing, and operations for Tilray's medical and adult-use cannabis business.

Tilrayhas been active in acquisitions, with an eye toward moving into the U.S. market, once that is allowed. In May, it completed its merger with another Canadian cannabis company, Aphria, one of the biggest moves by a cannabis company this year. In August, the company purchased a majority position of outstanding senior secured convertible notes in troubled cannabis companyMedMen Enterprises, which has 24 retail locations through six U.S. states. Tilray already owns Sweetwater Brewing and MacNeil's expertise in the beverage industry will help Tilray in the cannabis-infused beverage market.

Another factor in Tilray's rise on Tuesday was that it was a good day for several cannabis companies, and Tilray, long a meme favorite, was buoyed when it appeared the slump of cannabis stocks might be ending.Canopy Growth andCronos Groupwere both up more than 7% on the day and theETFMG AlternativeHarvest ETFwas up more than 5%.

Now what

It remains to be seen how long Tilray can rally. Thecannabis stockhas been highly volatile -- with its 52-week high at $67 and its 52-week low at $5.25. The company isn't showing a net profit and it reported a $34.6 million loss in the company's fiscal 2022 first-quarter report. However, it was also the company's tenth consecutive quarter of positive adjustedEBITDAand net revenue was reported as $168 million, up 43% year over year.

While Tilray has been a retail investor favorite, it appears to be likely a better play as a long-term buy. The company is making aggressive moves to position itself to be a bigger player in the United States if federal laws are relaxed regarding cannabis.

免责声明:本文观点仅代表作者个人观点,不构成本平台的投资建议,本平台不对文章信息准确性、完整性和及时性做出任何保证,亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

发表看法
8